Profiel
Amin Kamel formerly worked at Takeda Pharmaceuticals International, Inc., as Scientific Director and Regulus Therapeutics, Inc., as Vice President-DMPK from 2022 to 2025.
Dr. Kamel received his doctorate degree from the University of Rhode Island.
Eerdere bekende functies van Amin Kamel
| Bedrijven | Functie | Einde |
|---|---|---|
| REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | 25-06-2025 |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Amin Kamel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Rhode Island
University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regulus Therapeutics, Inc.
Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
















